(DIR) Home
        
        
       AstraZeneca withdraws its COVID-19 vaccine worldwide
        
 (HTM) Source
        
       ----------------------------------------------------------------------
        
       AstraZeneca says it is withdrawing Vaxzevria, its vaccine to protect
       against COVID-19, from global markets. The vaccine was used early on
       in the pandemic in many countries, including Canada.
        
       In an update on the European Medicines Agency's website on Wednesday,
       the regulator said that the approval for Vaxzevria had been withdrawn
       "at the request of the marketing authorization holder."
        
       More than three **** billion doses of the vaccine have been supplied
       since it first was administered in the United Kingdom in January 2021.
        
       AstraZeneca said as multiple vaccines against newer variants of the
       pandemic coronavirus have been developed, there is a surplus. Demand
       for Vaxzevria declined and the company said it is no longer being
       manufactured or supplied.
        
       _**WATCH | AstraZeneca COVID-19 vaccine pulled:**_
        
       ### Vaccine complications explained
        
       Dr. Samir Gupta on science working as it should with AstraZeneca's
       COVID vaccine
        
       Dr. Samir Gupta, a respirologist at St Michael's Hospital in Toronto,
       said what's important is that the creation of the AstraZeneca vaccine,
       testing, roll out, discovery of complications and stopping of vaccine
       distribution played out as it should for a new pandemic virus.
        
       According to media reports, AstraZeneca previously admitted in court
       documents that the vaccine can cause rare side-effects such as blood
       clots and low blood platelet counts.
        
       "Ultimately we can't forget that the virus is worse than the vaccine,
       even with this complication," Gupta said in an interview on CBC News
       Network.
        
       AstraZeneca's application to withdraw the vaccine was made on March 5
       and came into effect on May 7, according to the Telegraph, which first
       reported the development.
        
       The Serum Institute of India (SII), which produced AstraZeneca's
       COVID-19 vaccine under the brand name Covishield, stopped
       manufacturing and supply of the doses since December 2021, an SII
       spokesperson said.
        
        
        
        
       ______________________________________________________________________
                                                 Served by Flask-Gopher/2.2.1